CJ. Thanks for the info. Sold a long position in InMed mid week. Thought that one was a sure thing. Not saying it is over but lots of questions with patent, insider selling, and options with Bogart boys at the moment. Valuation way off as well compared to Nemus. Was in nemus last year got out without much damage. Hate not having money in bio medical side of this space. Emerald taking a bit of a hit lately as well. Any thoughts would be appricated as you don’t post much but yet seem knowledgeable in the space. Cheers.
News 
Market Data 
Discover 
